DoctorDirectory.ai
Menu

Dr. Guillermo Umpierrez, MD

Not yet claimed

Endocrinologist, Diabetes doctor · Physician (MD)

Atlanta, GA

Not yet claimed. This listing was researched from public sources and screened against our eligibility rules, but the provider has not yet claimed it, verified the details, or attested to guideline-based care. Are you Guillermo Umpierrez? Claim this profile.

Dr. Guillermo Umpierrez is an endocrinologist on the faculty of Emory University School of Medicine in Atlanta, Georgia. His listed area of focus is endocrinology, diabetes, and metabolism.

About Dr. Guillermo Umpierrez, MD

Updated Sep 20, 2026 · next review Dec 19, 2026

Dr. Guillermo E. Umpierrez is an endocrinologist in Atlanta, Georgia. He is a Professor of Medicine in the Division of Endocrinology, Metabolism and Lipids at Emory University School of Medicine, and he serves as Chief of Diabetes and Endocrinology at Grady Health System. He is also clinical director of Emory's Diabetes and Metabolism Center and directs the clinical research unit at Grady Memorial Hospital.

He earned his medical degree at the University of Guayaquil in Ecuador and completed his internal medicine residency and endocrinology fellowship at Emory University School of Medicine. He is board certified in internal medicine and endocrinology.

Much of his work focuses on managing diabetes and high blood sugar in people who are in the hospital. He was the first author of a 2024 consensus report on hyperglycemic crises (such as diabetic ketoacidosis) written jointly by the American Diabetes Association, EASD, JBDS, AACE, and the Diabetes Technology Society. He also writes a regularly updated review chapter on managing diabetes in hospitalized patients, and he served as the American Diabetes Association's 2022 President of Medicine & Science.

Public records show payments from drug and device companies. Between 2021 and 2025, CMS Open Payments recorded $56,917.59 across 89 records, with the largest amounts from Sanofi Pasteur, Dexcom, Sanofi-Aventis, Recordati Rare Diseases, and Bayer Healthcare Pharmaceuticals. Payments from industry to doctors are common and legal, and are often tied to research or speaking work.

Emory professor and Grady chief
He is a Professor of Medicine at Emory University School of Medicine and Chief of Diabetes and Endocrinology at Grady Health System. hip.emory.edu
Board certification
He is board certified in internal medicine and endocrinology, a Fellow of the American Association of Clinical Endocrinology, and a Master of the American College of Physicians. diabetes.emory.edu
Training
He received his medical degree from the University of Guayaquil in Ecuador and completed his internal medicine residency and endocrinology fellowship at Emory University School of Medicine. news.emory.edu
Led 2024 guideline on diabetic crises
He was first author of the 2024 consensus report 'Hyperglycemic Crises in Adults With Diabetes,' published in Diabetes Care by a joint ADA/EASD/JBDS/AACE/DTS panel. diabetesjournals.org
Hospital diabetes expertise
He authors the Endotext chapter 'Management of Diabetes and Hyperglycemia in Hospitalized Patients,' last updated in October 2024. ncbi.nlm.nih.gov
American Diabetes Association leadership
He served as the 2022 President, Medicine & Science of the American Diabetes Association and sat on its National Board of Directors. diabetes.org
Journal editor
He is Editor-in-Chief of BMJ Open Diabetes Research & Care and of the ADA's Medical Management of Diabetes clinical series. ssciweb.org
Research output and awards
An AACE biography describes him as an author of more than 500 scientific manuscripts and book chapters and a principal investigator in hospital diabetes management trials; he holds the Master of the AACE distinction. pro.aace.com
National clinical award
He received the American Diabetes Association's 2013 Outstanding Physician Clinician in Diabetes Award. news.emory.edu
Industry payments on record
CMS Open Payments lists $56,917.59 across 89 records from 2021 to 2025, with the largest amounts from Sanofi Pasteur ($14,214), Dexcom ($11,502.88), and Sanofi-Aventis ($10,602.21). openpaymentsdata.cms.gov

Worth knowing

  • After his 2024 hyperglycemic crises consensus report was published, other researchers submitted comment letters to Diabetes Care raising questions about parts of it, and the authors published a response. Scientific correspondence of this kind is a normal part of guideline publishing. diabetesjournals.org
  • The research for this profile did not find any license discipline, lawsuits, or criminal matters. However, a direct licensee lookup with the Georgia Composite Medical Board and a court-records search were not completed, so this is not a confirmed clean record. medicalboard.georgia.gov

Industry payments (CMS Open Payments)

Open the CMS record

Federal law requires drug and device companies to report what they pay clinicians: meals, travel, speaking, consulting, and research. Payments are common and legal; the point is that you can see them.

2021 to 2025

$56,918

89 payments

2021$2,113
2022$38
2023$11,492
2024$11,272
2025$32,003

Top payers

  • SANOFI PASTEUR INC.$14,214
  • Dexcom, Inc.$11,503
  • SANOFI-AVENTIS U.S. LLC$10,602
  • RECORDATI_RARE_DISEASES_INC.$6,371
  • Bayer Healthcare Pharmaceuticals Inc.$5,660

Payment types

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$25,157
  • Consulting Fee$8,816
  • Compensation for serving as faculty or as a speaker for a medical education program$8,760
  • Travel and Lodging$5,763
  • Honoraria$5,100

A word of caution about these numbers

A payment does not mean your doctor is compromised or acting unethically. Most of these entries are drug samples left for patients, or lunch brought in for the office staff, and the amounts are usually small. Research funding and speaking at medical meetings are also normal parts of a clinical career.

As a rough guide, a total under $15,000 a year is usually not a concern. Much larger sums, especially from one company whose product your doctor recommends to you, are worth asking about. You are allowed to ask.

Sources: med.emory.edu · diabetes.emory.edu · hip.emory.edu · med.emory.edu · news.emory.edu · pro.aace.com · diabetesjournals.org · pubmed.ncbi.nlm.nih.gov. Something wrong or out of date? Tell us and we will correct it.

Summary prepared with AI assistance from the public sources linked above, reviewed every three months. It is not a review, a rating, or an endorsement.

Practice location

Something wrong with this profile? ·